And not just that, these labels seemingly nudged consumers towards medicinal dosages of this unsanctioned drug.
However, this D.C. case quickly crumbled when Hi-Tech played its card, asserting its immunity from the court’s jurisdiction.
Unyielding, Smith, now hailing from Maryland, picked up the gauntlet again in 2019, throwing it down in Georgia, Hi-Tech’s home turf.
By June 2022, the legal scales tilted, and an appeals court stamped its approval on the original judgment that the FDA reigns supreme in this dietary duel.
But in a twist, the court flipped its decision regarding Smith’s claims under the D.C. Consumer Procedures and Protection Act.
Diet Supplement Labeling Suit : What’s Next in this Legal Labyrinth?
With both Smith and Hi-Tech unsatisfied, they reached out to the state’s apex court. Yet, as the curtains fall on this act, their representatives remain unreachable, leaving the audience on the edge of their seats, eagerly awaiting the next move.
